Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

    A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

    • Autoimmune Disorder
    • Inflammatory Bowel Disease (IBD)
    • Ulcerative Colitis

    For the latest version of this information please go to www.forpatients.roche.com